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Abstract: Inflammatory bowel disease have been linked to several health issues, including high
risk of low bone mineral density. Danio rerio (zebrafish) is a good model to verify the effects of
intestinal inflammation, since its gastrointestinal and immune systems are closely related to that
of mammalians. Zebrafish is also a powerful model to study bone metabolism using the scale as
the read-out model. Food strongly impacts zebrafish gut physiology, and it is well known that
soybean meal induces intestinal inflammation. Adult zebrafish fed with defatted soybean meal
(SBM) exhibited an intestinal inflammation evidenced by morphological alterations, inflammatory
infiltrate, and increased mRNA expression of inflammatory cytokines (IL-1β, IL-6, IL-8, IL-10, TGFβ,
TNF-α). The peak of acute intestinal inflammation, spanning between week 2 and 3, correlates
with a transitory osteoporosis-like phenotype in the scale border. Later, a chronic inflammatory
condition, associated with persistent IL-8 expression, correlates with the progression of resorption
lacunae in the scale center. Both types of resorption lacunae were associated with intense osteoclastic
tartrate-resistant acid phosphatase (TRAP) activity. After 3 weeks of SBM treatment, osteoclast
activity decreased in the scale border but not in the center. At the same time, alkaline phosphatase
(ALP) is activated in the border to repair the bone matrix. This model can contribute to elucidate
in vivo the molecular mechanisms that links intestinal inflammation and bone metabolism in IBD.
Keywords: zebrafish; bone; osteoporosis; inflammatory bowel disease; intestinal inflammation;
scale; soy
1. Introduction
Inflammatory bowel disease (IBD) was linked to several health issues in human
patients, including high risk of low bone mineral density and increased risk of fractures [1].
Danio rerio (zebrafish) is an excellent model to verify the various adverse effects of intestinal
inflammation, including any effects on bone tissue. In fact, zebrafish is a powerful model
to study bone tissue in the adult organism using the scale as read-out model due to
its high accessibility, number of samples, bone tissue similarity, and transparency [2].
Furthermore, it must also be considered that the zebrafish immune system is highly related
to that of mammals in both the innate and adaptive branches [3]. Moreover, the zebrafish
gastrointestinal system is closely analogous to that of mammalians, even if it is simpler
and lacks a definite stomach. In fact, the zebrafish intestinal tract consists of a twice-
folded long tube located in the abdominal cavity and is arbitrarily divided based on
morphological characteristics in the intestinal bulb, the mid and the posterior intestinal
segments. Zebrafish intestine has comparable absorptive and secretory functions with those
of mammals and is itself organized in concentric layers, even if supporting connective tissue
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layers are less complex and it lacks specific muscularis mucosa. Furthermore, zebrafish
intestine is organized in irregular folds rather than well-defined crypts and real villi [4].
In the last decade, several gastrointestinal pathologies were reproduced in zebrafish
using both chemicals and genetic models [5]. Chemical models were created using oxa-
zolone, 2,4,6-trinitrobenzene sulfonic acid (TNBS), and dextran sodium sulfate (DSS) [5]
and are characterized by increased expression of pro-inflammatory cytokines, such as
interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNFα); eosinophil infiltra-
tion [6]; and different degrees of morphological changes in the intestine and of impaired
gut functions [5]. An elevated level of TNFα is considered a key factor to determine the
establishment of IBD even in zebrafish since Marjoram et al. confirmed this correlation
using an inflammation-responsive transgenic zebrafish line (TgBAC TNFα: GFP) [7].
Soybean meal (SBM) has become the primary protein source in fish diet replacing
fishmeal thanks to its high availability and low cost. Nevertheless, studies reported that
SBM induces enteritis, a type of intestinal inflammation, in aquaculture fish species, such
as Atlantic salmon [8–13], rainbow trout [11], common carp [14], juvenile turbot [15], and
zebrafish larvae [16] and that the actual inflammatory component of soy-based meal is
saponin. Saponins are amphiphilic molecules, steroid or triterpenoid glycosides, common
in a large number of plants and plant-derived products, with different biological activ-
ities [17]. Saponins’ mechanism of action in the intestinal membranes in vivo is not yet
completely understood, but they certainly have the ability to increase the epithelial perme-
ability of the intestine affecting nutrient uptake [18] and inducing intestinal inflammation
in adult fish [19–21].
It is known that soluble factors like hormones, cytokines, growth factors are able
to modulate bone metabolism. In particular, local and systemic inflammatory changes
influence the bone microenvironment resulting in alterations leading to bone loss compli-
cations [22,23]. An understanding of the physiological and pathological mechanisms that
regulates these changes, still largely unknown, will help to find new therapeutic strategies
against bone-loss diseases associated to inflammatory conditions.
The aim of this study was to analyze bone tissue alterations in an adult zebrafish
model due to experimental IBD induced by SBM treatment.
2. Materials and Methods
2.1. Ethic Statement
This experimentation was performed in the Zebrafish Laboratory (IRCCS R. Galeazzi,
GSD Foundation, Milan, Italy) according to the Italian and European guidelines on research
practice (EU Directive 2010/63/EU). Zebrafish experimentation and all protocols of this
study were approved by Ministry of Health (authorization n. 742/2019-PR).
2.2. Animals
Adult 9 months old zebrafish of AB strain were maintained in the ZEBTEC© Bench Top
system (Tecniplast Spa, Buguggiate, Italy) according to standard conditions [24]. During
the experimentation fish were maintained at 28 ◦C in fish water from the aquarium system.
In the experiment, 55 fish were used with three replications for a total of 165 fish. Five fish
were used at the beginning of the test to check the physiological state of the population,
then 25 fish were fed a standard diet and 25 an experimental diet. The experiment lasted
5 weeks, and every week, five fish from each group were sampled and analyzed.
2.3. Diets
Standard fish food (Vipagran, Sera GmbH, Heinsberg, Germany) was used as a control
soy-free diet (CTR). The experimental diet was formulated based on a previous study
performed on zebrafish larvae [16] that demonstrated that soy saponin, a protein found in
low amount in soybean flour, is responsible for the intestinal inflammatory process. This
diet ensured a high saponin content because we used soybean flour type I (Sigma Aldrich,
St. Louis, Missouri, USA), a specifically defatted soybean flour with high protein content
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(protein ~52% (85+% dispersible and 1% fat)) and consequently an increased saponin
concentration. The experimental diet (SBM) was composed of 50% w/w control diet and
50% w/w soybean flour, mixed with some water, then dried, and reduced in size to crumbs
suitable for zebrafish consumption. Fish were fed with an automated system 3 times a day
for 5 weeks (T1–T5).
2.4. Samples Collection
Fish were euthanized using a 300 mg/L tricaine methanesulfonate (Sigma Aldrich,
St. Louis, MO, USA) solution [25]. Zebrafish intestines were isolated using sterile scalpels
(Paragon®, Maersk Medical LTD, Sheffield, England) and stored in DNA/RNA Shield
(Zymo Research, Irvine, CA, USA). Scales were carefully removed from either side of the
fish body using Dumont® Stainless Steel Forceps (Sigma Aldrich) and processed differently
depending on the analysis to be performed as described below. All samples were isolated
using a light stereomicroscope (Olympus SZX-ZB7, Olympus, Tokyo, Japan).
2.5. Histological Analysis and Morphometric Measures
Microscopic analyses were conducted in collaboration with Dr. Anna Maria Chiar-
avalli, U.O. di Istologia e Anatomia Patologica, Ospedale di Circolo, ASST-Sette Laghi,
Viale L. Borri 57, 21,100 Varese, Italy. Fresh samples were fixed in a 10% formalin buffer
for 12 h in a w/w 20:1 ratio. For perfect dehydration and fixing processes, we used the Do-
natello Fast (Diapath, Martinengo, Bergamo, Italy) automatic processor. Samples were then
embedded in paraffin with the Leica EG1150H automated system. For optic microscopy,
transversal sections of 8–10 µm thickness were obtained with the Leica biosystem RM2235
microtome (Leica, Wetzlar, Germany). Sections were then stained with hematoxylin-eosin
and observed on an optic microscope (Leica DMRA, Laica, Wetzlar, Germany). Images
were acquired with a Nikon D5-5M camera (Nikon, Tokyo, Japan), and the thickness of
mucosa was evaluated using imaging software.
2.6. Myeloperoxidase Staining and Cell Count
Deparaffinization of 8 µm thick formalin fixed paraffin embedded (FFPE) sections was
performed following standard protocols. Slides were mounted on poly-L-lysine-coated
slides, heated in an oven (60 ◦C, 30 min) and rehydrated through an alcohol series to
water. Endogenous activity was blocked with 3% hydrogen peroxide solution for 12 min
and antigen retrieval was obtained by 10mM Citrate Buffer (pH 6) treatment. Slides
were incubated overnight at 4 ◦C with a rabbit polyclonal anti-myeloperoxidase (MPO)
primary antibody (ab210563, Abcam, Cambridge, England, UK; 1:100 dilution) followed
by goat anti-rabbit IgG H&L (HRP) (ab6721, Abcam, Cambridge, England, UK; 1:200
dilution) secondary antibody for 1 h and ABC peroxidase complex. To localize MPO,
3,3′-diaminobenzidine tetrahydrochloride (DAB) was added. The immunohistochemical
reaction was developed with diaminobenzidine–hydrogen peroxide reaction, and sections
were counterstained with hematoxylin. The immune cells evaluation was performed by
counting the MPO-positive cells present in a defined area of each histological section
respect to total cells.
2.7. Intestinal Gene Expression Analysis and Inflammatory Status Estimation
Total RNA extraction was performed using the EuroGold Total RNA Mini kit (Eu-
roclone, Milan, Italy) according to the manufacturer’s instructions, then RNA was quan-
tified with Nanodrop® ND 100 (Thermo Fisher Scientific, Waltham, MA, USA), and its
integrity was verified on a 2% agarose gel. cDNA was synthesized from RNA sam-
ples with the High-Capacity cDNA synthesis kit (Applied Biosystems, Foster City, CA,
USA) according to the manufacturer’s instructions. Quantitative real-time PCR (qRT-
PCR) analysis was performed using AB PRISM 7000 (Applied Biosystem, Foster City,
CA, USA) instrument with 30 ng of cDNA per well with the SYBR green (Power SYBR
green Universal PCR Master Mix, Promega, Pero, Milan, Italy) method (thermal pro-
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file was: 50 ◦C for 2 min, 95 ◦C for 10 s and 40 cycles of 95 ◦C for 15 s, and 60◦C
for 1 min). Analyses were performed with the Ct method using β actin as an endoge-
nous control. Then the average ∆Ct value was calculated by subtracting the control ∆Ct
from the treated ∆Ct, and the relative quantity of mRNA was calculated as 2-∆∆Ct [26].
The genes studied were Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8),
Interleukin-10 (IL-10), Transforming growth factor-β (TGFβ), and Tumor necrosis factor-α
(TNF-α). The PCR amplification was performed using the primers for IL-1β (sense: 5′-
CAGATCCGCTTGCAATGA-3′; antisense: 5′-TTGTGCTGCGAAGTCCAC-3′), IL-6 (sense:
5′-AAGGGGTCAGGATCAGCAC-3′; antisense: 5′-GCTGTAGATTCGCGTTAGACATC-3′),
IL-8 (sense: 5′-GCAAAATCATTTCAGTGTGTGTT-3′; antisense: 5′-CAGACCTCTCAAGC-
TCATTCC-3′), IL-10 (sense: 5′-AACTCAAGCGGGATATGGTG-3′; antisense: 5′-GACCCC-
CTTTTCCTTCATCT-3′), TGFβ (sense: 5′-AATGGCTGCAGGGTTCAG-3′; antisense: 5′-
GGTTTGCTTTACAGTCGCAGT-3′), and TNFα (sense: 5′-AGGCAATTTCACTTCCAAGG-
3′; antisense: 5′-AGGTCTTTGATTCAGAGTTGTATCC-3′) designed with the Primer3 free
online software (version 4.1.0, https://primer3.ut.ee/).
To estimate the actual intestinal inflammatory status, we slightly modified the inflam-
matory index formula created by Bond et al. [27]. Briefly, for each sampling time every
detected level of the cytokines was converted to a “Z-score”. Then the “inflammatory
index” was calculated as the sum of the Z-scores of IL-1, IL-6, IL-8, and TNF-α, while the
“anti-inflammatory index” coincides with the TGFβ and IL-10 Z-score. For each sampling
time, the “anti-inflammatory index” was subtracted from the “inflammatory index” to
obtain the “Total inflammatory index”.
2.8. Bone Matrix Vital Staining
To highlight the scale mineralized matrix resorption and its new deposition, fish were
double-stained with successive pulses of vital staining according to the method published
by Kimmel et al. [28]. At the beginning of the experiment, all fish were stained with
0.005% Alizarin Red S (Sigma Aldrich, St. Louis, MO, USA) solution overnight in the
dark. Then fish were divided into the two diet groups, and at the end of every week of
treatment, 5 SBM and 5 CTR fish were isolated and stained with 0.005% Calcein (Sigma-
Aldrich) solution overnight in the dark. After repeated washes, scales were collected from
these fish as previously described, fixed for 15 min in 3.5% formaldehyde 0.1 M sodium
phosphate buffer solution, and analyzed using a fluorescence microscope (Olympus SZX-
ZB7, Olympus, Tokyo, Japan) collecting and elaborating images with Discovery CH30
camera (Tiesselab, Milan, Italy).
2.9. Histological TRAP and ALP Assay in Scales
Histological tartrate resistant acid phosphatase (TRAP) activity was evaluated in the
explanted scales using the Leukocytes Acid Phosphatase Detection Kit (Sigma-Aldrich)
processing the samples according to manufacturer’s protocol. A histological ALP assay
was performed using BCIP®/NBT liquid substrate (Sigma Aldrich) according to the manu-
facturer’s protocols. Histological assays, as well as biochemical assays, were performed
separately after scale cut, since the zebrafish scale presents two different parts; the anterior
part is composed mainly of bone tissue, and the posterior part is covered by epidermis. In
this way it was possible to highlight the different bone marker expression in the two parts
of the scale. Moreover, the epidermis has blood vessels that express high levels of ALP,
compromising the efficiency of the histological ALP analysis.
2.10. Biochemical TRAP and ALP Scale Assays
Biochemical alkaline phosphatase (ALP) and TRAP activities were evaluated on ex-
planted scales following previously published methods [29,30] and reading the absorbance
levels at 405 nm using a spectrophotometer (iMarkTM Microplate Reader, Bio-Rad, Her-
cules, CA, USA).
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2.11. Statistics
Five SBM fish and five CTR fish were tested at the end of each week of treatment, and
the entire experiment was replicated three times. PCR experiments were repeated with
comparable results at least three times and evaluated through statistical analysis using
Student’s t-test. Significance values were set at p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
Biochemical scales analyses of ALP and TRAP activity were performed using 20 scales per
fish for each analysis, while histological assays were performed on 50 scales. Bone matrix
vital staining analysis was evaluated on 20 scales for each fish. All the collected data were
analyzed using Student’s t-test and results expressed as mean ± standard deviation vs.
control. Significance values were set at less than p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
3. Results
3.1. Soybean Meal Induces Intestinal Inflammation in Adult Zebrafish
Adult zebrafish were fed for 5 weeks with 50% w/w soybean meal (SBM) and com-
pared with control soy-free diet (CTR). After each week of treatment, fish intestines were
sampled for morphological and histochemical analysis of the gut wall. The total wall thick-
ness significantly increased after two weeks of SBM treatment and then returned to the
physiological state at T4 (Figure 1A). The percentage of immune cells which infiltrated the
intestinal wall was evaluated by myeloperoxidase (MPO) staining. The SBM diet induced
an increase of immune cells from two weeks in the intestinal mucosa (Figure 1B).
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Figure 1. Morphometric and infiltrate analysis of the gut wall. Fish were fed with a soy-supplemented
diet for one (T1), two (T2), three (T3), four (T4), and five (T5) weeks or normal diet (CTR). (A) The total
wall thickness was found increased after two and three weeks of treatment (T2 vs. CTR, p < 0.001;
T3 vs. CTR, p < 0.05). (B) The percentage of MPO- ositive immune cells was found increased in the
submucosal layer of SBM-treated fish starting from T2 (T2 vs. CTR, p < 0.001; T3 vs. CTR, p < 0.001;
T4 vs. CTR, p < 0.001; T5 vs. CTR, p < 0.01). Significance values were set at les than p < 0.05 (*),
p < 0.01 (**), and p < 0.001 (***).
After 2 weeks of treatment, RT-PCR analysis (Figure 2) of intestinal total RNA revealed
increased levels of pro-inflammatory cytokines IL-1β, IL-6, IL-8, and TNFα, as well as the
anti-inflammatory cytokine TGFβ and IL-10. After 3 weeks of treatment, the cytokines
gene expression returned to be comparable to control, except IL-8 and TNFα. Interestingly,
after 4 and 5 weeks, only IL-8 increased again.
Biomedicines 2021, 9, 393 6 of 14
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Figure 2. Gene expression analysis by RT-PCR for inflammatory marker genes on zebrafish intestine untreated (CTR) or
treated with SBM for one (T1), two (T2), three (T3), four (T4), and five weeks (T5). IL-6 IL-10, TGFβ, IL-1β, IL-8, and TNFα
resulted to be statistically significantly increased after two weeks (IL-1β: CTR vs. T2, p < 0.001; IL-8: CTR vs. T2, p < 0.001;
IL-10: CTR vs. T2, p < 0.001; TGFβ: CTR vs. T2, p < 0.001; IL-6: CTR vs. T2, p < 0.001; TNFα: CTR vs. T2, p < 0.05) and IL-8
and TNFα after three weeks (IL-8: CTR vs. T3, p < 0.05; TNFα: CTR vs. T3, p < 0.01). After four and five weeks of treatment,
only IL-8 resulted to be significantly increased (IL-8: CTR vs. T4, p < 0.001 and IL-8: CTR vs. T5, p < 0.001, respectively).
Significance values were set at less than p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
3.2. Soybean-M al Induces a Transie t Bone R sorption in the Scale Border
Bone alteration can be evaluated in the adult fish using the scale as a read-out system.
Part of the dermal skeleton was anatomically characterized in Figure 3A.
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Figure 3. Schematic representation of the adult zebrafish scale (A) The “center” is located in the
anterior part of the scale, whereas the “border” is in the posterior part. (B) Resorption lacunae in the
posterior part are distributed along the border, while in the anterior part, they are concentrated in
the center.
Three weeks of SBM treatment induce the alteration of bone markers TRAP in fish
scales, indicative of osteoclastic activity. The histological TRAP activity assay highlighted a
relevant osteoclast activity along the scale borders of SBN-treated fish after 3 weeks (T3),
whereas it became less intense at T4 and disappeared after 5 weeks (T5) (Figure 4A, black
arrows). The percentage of scale borders with TRAP activity corresponds to 30% and 10%,
Biomedicines 2021, 9, 393 7 of 14
respectively, at T3 and T4 (Figure 4B). Moreover, a significant TRAP activity can be detected
in treated fish after 3 weeks (T3) by biochemical assay, followed by a rapid decrease at T4
and absence of signal at T5 (Figure 4C).
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Figure 4. (A) The histological TRAP activity assay highlighted resorption activity along the anterior border of the scale after
3 (T3) and 4 (T4) weeks of treatment, whereas no activity was found in the scales of untreated fish (CTR), T1 (not shown), T2
(not shown), and T5. The percentage indicates the representation of the picture phe otype respect the total scal s (scale bar:
0.1 mm). (B) The percentage of scales with detectable TRAP activity staining was 30% and 10%, respectively, at T3 and T4
(CTR vs. T3, p < 0.001; CTR vs. T4, p < 0.05). The value of the control at each experimental point was omitted, as it was
identical to the initial CTR. (C) The biochemical TRAP activity assay indicated a peak in resorption activity in the scale after
3 weeks (T3) (CTR vs. T3, p < 0.001). Then it rapidly decreased at T4 (CTR vs. T4, p < 0.01) and returned to the control level
at T5. The value of the control at each experimental point was omitted, as it was identical to the initial CTR. Significance
values were set at less than p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).
3.3. Anabolic Stimuli Rescued Osteoporotic Phenotype in the Scale Border
Calcein live staining confirmed the presence of bone matrix resorption lacunae after
3 weeks of SBM treatment, detectable as bone-loss area in the posterior part of the scale,
along the border (Figure 5A, T3, white arrowhead and Figure 3B) and covering an average
of 4.5–5.0% of the scale surface (significant with p < 0.001). These resorption lacunae were
filled by new mineralized matrix starting in the fourth week of treatment (Figure 5A, T4,
white arrows) and concluded in the fifth week (Figure 5A, T5). New matrix deposition can
be evidenced by more intense green staining filling the lacunae area. The percentage of
resorbed scales reached 40% of the total in T3 but decreased in T4 (10%) and vanished at
T5 (0%). In the meantime, the anabolic process, starting at T3, increased the percentage
of repaired scales at T4 (30%) and terminated at T5 (40%) (Figure 5B). After 5 weeks, all
lacunae were filled by new mineralized matrix in scale border (Figure 5C).
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Figure 5. (A) Calcein vital staining of scales from treated fish and untreated controls. Control scale show normal profile,
while scales from treated fish show bone resorption lacunae after 3 weeks of treatment (T3, white arrowhead). At 4 eeks of
SBM treatment, the lacunae started to fill by new matrix deposition (T4, white arrows) and appeared completely repaired in
the fifth week (T5) (scale bar: 0.1 mm). (B) Percentage of resorbed scales versus repaired scales. T e percentage of resorbed
scales decreased as the percentage or r paired scales increas d (r sorbed scales: CTR vs. T3, p < 0.001; CTR vs. T4, p < 0.05;
repaired scales: CTR vs. T4, p < 0.001; CTR vs. T5, p < 0.001). (C) Alizarin Red-calcein double staining shows that the
resorbed area was completely filled by new matrix at the end of the fifth week (green signal in T5) of SBM treatment in all
scales. Untreated control (CTR) is shown as reference (scale bar: 0.07 mm). (D) Biochemical ALP activity assay indicates a
peak in anabolic activity in the scale after 3 weeks of treatment (T3) (CTR vs. T3, p < 0.001). The value of the control at each
experimental point was omitted as it was identical to the initial CTR. Significance values were set at less than p < 0.05 (*),
and p < 0.001 (***).
The analysis of the posterior part of th scales, highlights that SBM treatment does
not reduce osteoblastic ALP activity. On the contrary, an up regulation was biochemically
detected in treated fish after 3 weeks (T3), confirming the activation of bone anabolic
functions in the border area (Figure 5D).
3.4. Soybe n-Meal Induces a Permanent Bone Resorption i he Scale Center
Histological TRAP activity assay detects another rel vant osteoclast activity in the
central area of the scale in 3 weeks (T3) SBM-treated fish, where the staining increased
progressively from T3 to T5 as well as the resorbing surface (Figures 6A and 3B). The per-
centage of scale with central TRAP activity corresponds to 50%, 70%, and 80%, respectively,
at T3, T4 and T5 (Figure 6B). Moreover, a significant and progressive increase of TRAP
activity was d tected in SBM-fish after e ks (T3) by iochemical ass y (Figure 6C).
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80% of scales after 3, 4, and 5 weeks, respectively, of SBM treatment and associated with a 
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area of SBM-fish scales (Figure 7C). 
Figure 6. (A) Histological TRAP activity assay highlights resorption activity along the central area of the scale after 3 (T3),
4 (T4), and 5 (T5) weeks of treatment, whereas no activity is found in the scales of untreated fish (CTR), T1 (not shown) and
T2 (not show ) (sc le bar: 0.1 mm). (B) The percentage of scale with detectable TRAP activity staining is 50%, 70% and 80%
respectively at T3, T4 and T5 (CTR vs. T3, p < 0.001; CTR vs. T4, p < 0.001 CTR vs. T5, p < 0.001). The value of the control at
each experimental point was omitted as it was identical to the initial CTR. (C) Biochemical TRAP activity assay indicates
a significant resorption activity in the center of scales after 4 and 5 weeks (T4 and T5) (CTR vs. T4, p < 0.01; CTR vs. T5,
p < 0.001). The value of the control at each experimental point was omitted as it was identical to the initial CTR. Significance
values were set at less than p < 0.01 (**), and p < 0.001 (***).
3.5. Osteoporotic Phenotype in the Scale Center Is Not Rescued by Anabolic Stimuli
Calcein live staining confirms the presence of resorption lacunae in 50%, 70% and
80% of scales after 3, 4, and 5 weeks, respectively, of SBM treatment and associated with a
progressive increase of the resorbed area (Figure 7A, white arrowhead). Absence of new
matrix deposition can be evidenced into the lacunae area. The SBM treatment reduced the
biochemical ALP activity in the anterior half of the fish scales significantly at T5 (Figure 7B)
which corresponds to a downregulation of ALP staining signal in the central area of
SBM-fish scales (Figure 7C).
3.6. Different Inflammatory Stimuli Causes Different Bone Loss Patterns in Zebrafish Scales
In order to correlate the course of intestinal inflammatory markers and the bone effects,
we used the “inflammatory index” [27] to quantify the inflammation in our model. In
this way, we can estimate that the “total inflammatory index” (TII) of SBM-tr ated fish
generates a curve with maximal values at T2 and T4/5, which represent the two peaks of
inflammatory activity in the intestine (Figure 8).
Biomedicines 2021, 9, 393 10 of 14Biomedicines 2021, 9, x FOR PEER REVIEW 10 of 14  
 
Figure 7. (A) Calcein vital staining of scales from treated fish and untreated controls. Control scale show normal profile, 
while scales from treated fish show central resorption lacunae after 3 weeks of treatment (T3, white arrow) (scale bar: 0.1 
mm). (B) Biochemical ALP activity assay indicates a downregulation of anabolic activity in the scale after 5 weeks of 
treatment (T5) (CTR vs. T5, p < 0.001). The value of the control at each experimental point was omitted as it was identical 
to the initial CTR. (C) Histological ALP assay confirmed the loss of enzymatic activity (white arrows) in the center of 
scales after 5 weeks of SBM treatment (scale bar: 0.1 mm). Significance values were set at less than p < 0.001 (***). 
3.6. Different Inflammatory Stimuli Causes Different Bone Loss Patterns in Zebrafish Scales 
In order to correlate the course of intestinal inflammatory markers and the bone ef-
fects, we used the “inflammatory index” [27] to quantify the inflammation in our model. 
In this way, we can estimate that the “total inflammatory index” (TII) of SBM-treated fish 
generates a curve with maximal values at T2 and T4/5, which represent the two peaks of 
inflammatory activity in the intestine (Figure 8). 
 
Figure 8. Total inflammatory index (TII) generated by expression of pro-inflammatory (IL-1β, 
TNF-α, IL-8 and IL-6) and anti-inflammatory (IL-10, TGFβ) genes in fish intestine. Total inflamma-
tory index peaks during the second week of SBM treatment to indicate the maximum activity of 
pro-inflammatory cytokines (IL-1β, TNF-α, IL-8, and IL-6). Next, TII dropped at T3, because of the 
Figure 7. (A) Calcein vital staining of scales from treated fish and untreated controls. Control scale show normal profile,
while scales from treated fish show central resorption lacunae after 3 weeks of treatment (T3, white arrow) (scale bar:
0.1 mm). (B) Biochemical ALP activity assay indicates a downregulation of anabolic activity in the scale after 5 weeks of
treatment (T5) (CTR vs. T5, p < 0.001). The value of the control at each experimental point was omitted as it was identical to
the initial CTR. (C) Histological ALP assay confirmed the loss of enzymatic activity (white arrows) in the center of scales
after 5 weeks of SBM treatment (scale bar: 0.1 mm). Significance values were set at less than p < 0.001 (***).
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Figure 8. Total inflam atory index (TII) gen rated by expression of pro-inflam atory (IL-1β, TNF-
α, IL-8 and IL-6) and anti-inflammatory (IL-10, TGFβ) genes in fi h intestin . Total inflammatory
index peaks during the second week of SBM treatment to indicate the maximum activity of pro-
inflammatory cytokines (IL-1β, TNF-α, IL-8, and IL-6). Next, TII dropped at T3, because of the effect
of the anti-inflammatory cytokines TGFβ and IL-10 and returned to increase in T4 and T5 because of
sustained IL-8 expression.
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The effect of anti-inflammatory (IL-10 and TGFβ) cytokines counteracted the pro-
inflammatory stimulus (IL-1β, IL-6, TNFα) in T2 and reduced the TII in T3, indicating that
acute inflammation phenomenon was suppressed while a residual inflammatory stimulus
remained at T3 with TNFα and IL-8 expression. Interestingly, TII reared up again when
IL-8 returned to being expressed at high levels, suggesting that a chronic inflammation
may substitute the acute one at fourth week.
Comparing the inflammatory index trend with the percentage of TRAP positive scales
(Figure 9), we observed that the resorbing activity in the scale border seems to be correlated
to the inflammatory pick at T2 suggesting a bone response to an acute inflammatory
stimulus. At T3, when the acute inflammatory state switched off, the resorbing activity
was not supported anymore, and a boost of osteoblastic ALP activity stimulated osteoblast
differentiation and activity in the refilling of border lacunae.
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Figure 9. Correlation between the percentage of TRAP positive scales (center and border) and the
total inflammatory index curve. TRAP activity in the scale border follows the inflammatory index
peak at T2, while TRAP activity in the center follows the late inflammatory index curve (T4 and T5).
4. Discussion
In two weeks, adult zebrafish fed with SBM developed an acute intestinal inflamma-
tion associated with increase of mucosal t ickness (edema), imm n cell infiltrate, and
expression of IL-1β and TNFα. These nd other pro-infl m atory markers, IL-6 and
IL-8, were widely raised after 3 w eks of SBM treatment to indicate a peak in an acute
inflammatory phenom non. The e data are supported by a previous study perform d by
Hedrera et al. [16] where a strong increase in IL-1β and IL-8 mRNA levels was detected in
z b afish l rvae fed with 50% SBM. IL-10, an anti-inflammatory cytokine that plays a role
also in zeb afish intestine [5], was raised at T3 suggesting the activatio of a compensatory
anti-inflammatory response, usually documented in the acut form of i flammation. The
increase o Il-10 completely turned off the intestinal flamma ory state i a week. The
same behavi r was demonstrated in a ult common carp intestine, where a soy-b sed diet
induced an intestinal acute inflammatory phenotype, from which fish recovered after three
weeks, once the primary t i fl t r stimulus was downregulated by IL-10 and
TGFβ expression [14].
Pro-inflammatory and anti-inflammatory cytokines maintain a dynamic balance of
the immune response in the health body, and this balance is dysregulated in IBD human
patients [1]. The pro-inflammatory cytokines are well known to directly promote bone loss.
IL-6 was identified as the main cytokine with a role in the pathogenesis of inflammatory-
induced osteoporosis. Moreover it was reported that genetic variations of IL-6 and IL-1
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receptor antagonist genes are strongly correlated with the clinical course of IBD and their
bone complications [31].
Our data suggest a correspondence in fish between the intestinal inflammatory pro-
cess and the osteoporosis in the scales. Interestingly, we also observed that two inflam-
matory peaks were temporally correlated with specific bone-loss phenotypes in the scales
(Figure 3B). In summary, border lacunae are strictly associated with the acute inflammatory
intestinal phenomenon evidenced at T3. The switch-off of an acute inflammatory peak
allows the bone to repair the bone-loss along the borders. Similarly, in common carp
intestine, a soy-based diet induced an acute inflammatory phenotype from which fish
recovered after three weeks while TNFα remained upregulated until the fifth week [14].
Moreover, it was reported that an acute burst of bone loss represents an important adaptive
program in acute inflammation where calcium and phosphorus are moved from bone to the
non-skeletal tissues [32]. The bone loss that is seen in an acute flare of colitis appears to be
very rapid at onset, but bone tissue can be successfully repaired in certain conditions [33].
On the other hand, central lacunae seem to be correlated to the late inflammatory peak
(T4-T5). The engagement of IL-8 in a second inflammatory phase suggests that a low-grade
pathological stimulus persists and stimulates a chronic inflammation state which supports
a specific bone-loss pattern in the central part of the scale. In fact, IL-8 is able to induce
osteoclastogenesis in different models [34–36].
It has been demonstrated that IL-8 can lead to chronic inflammatory conditions such
as rheumatoid arthritis [37] and psoriasis [38]. In patients with IBD, both neutrophils and
recruited macrophages are responsible for production of IL-8 [39], and recent human studies
also demonstrated that early recurrent ileal lesions in Crohn’s patients were characterized
by IL-8 production from neutrophils, whereas, in chronic lesions, IL-8 was produced by
macrophages and T cells [40].
The presence of acute and chronic phases can be demonstrated in many inflammatory
diseases associated with bone loss. For example, wear particles used of the artificial implant,
produce an acute inflammatory reaction which becomes chronic, with progressive synovitis
and bone destruction [41].
Different phases and localization of bone loss can be evidenced in many pathological
situations; in patients with rheumatoid arthritis, early rapid loss of cortical diaphyseal
bone is followed by gradual slowing [42]. Similarly, the glucocorticoid therapy causes first,
a rapid decrease of the bone mineral density (BMD) of about 6% to 12% in the first year
and an annual loss of about 3% thereafter [43].
On scale localization of bone resorption, further studies will elucidate the stimuli and
the mechanisms driving the activation of osteoclasts in different areas of the scale.
The results highlight that zebrafish represent an excellent model to study IBD in
adult organisms and in particular to study the inflammation-related complications. Ze-
brafish fed with SBM developed intestinal inflammation with different phases and different
bone remodeling patterns. This model can contribute to elucidate in vivo the molecular
mechanism and cellular cross-talk which regulate inflammation and bone remodeling.
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